Know More About Salmon Ovary Peptide

1. Inventor

Salmon Ovary Peptide, also known as Marine Placenta, was discovered and developed by inventor Tadashi Eto. It is extracted from the protective membrane of Oncorhynchus keta salmon eggs, a species found exclusively in the northern waters of Hokkaido, Japan.

2. Patent and Clinical Trials

Salmon Ovary Peptide has patented benefits that have undergone clinical trials and are recognized in multiple countries. It supports overall health by aiding the regeneration of damaged cells and improving blood circulation, helping reduce the risk of stroke, heart blockages, and other cardiovascular issues.

3. Japanese Craftsmanship

Professor Kikuchi formulated SOP Subarashi as an upgraded and refined version of SOP 100+, making it Indonesia’s first triple-peptide product (Salmon Ovary Peptide, Sardine Peptide, Fruitflow). This innovation reflects the Japanese concept of Monozukuri, emphasizing meticulous craftsmanship and dedication to quality.

4. Quality Assurance

SOP 100+ and SOP Subarashi are directly developed by Professor Kikuchi and closely supervised by Marine Placenta inventor Tadashi Eto. This ensures the safety, authenticity, and effectiveness of the products, guaranteeing that their benefits align with the patented claims.

5. Sole Exclusive Rights

AFC Indonesia holds exclusive rights as the sole distributor and seller of Salmon Ovary Peptide (Marine Placenta) products in Indonesia, officially authorized by the inventor.

6. Partnership

SOP Subarashi is the only AFC Japan product developed in collaboration with experts and scientists from other countries. For 51 years, AFC Japan never partnered with foreign companies, making this the first time AFC Lifescience has collaborated internationally to achieve optimal results.